Vivos Therapeutics (VVOS) Net Income towards Common Stockholders Growth (3y) (2023 - 2026)
Powered by 
Analysis
Vivos Therapeutics (VVOS) Net Income towards Common Stockholders Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn | -1.05% |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn | 1.14% |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn | -24.90% |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn | 13.98% |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | -29.81% |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn | 0.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.28% |
| Mar 31, 2026 | -65.23% |
| Dec 31, 2025 | -4.53% |
| Sep 30, 2025 | 0.21% |
| Jun 30, 2025 | 10.50% |
| Mar 31, 2025 | 10.17% |
| Dec 31, 2024 | 26.92% |
| Sep 30, 2024 | 21.72% |
| Jun 30, 2024 | 21.85% |
| Mar 31, 2024 | -3.45% |
| Dec 31, 2023 | 27.80% |
| Sep 30, 2023 | -0.48% |
| Jun 30, 2023 | -49.22% |
| Mar 31, 2023 | 15.58% |